Insulina i jej analogi - leki peptydowe stosowane w diabetologii

• Autorzy: Romaniuk, Krzysztof
• Języki publikacji: PL

Słowa kluczowe

PL

cukrzyca; insulina; preparaty insulinowe; analogi insuliny

EN

diabetes; insulin; insulin preparations; insulin analogues

• Czasopismo: Eliksir
• Rocznik: 2023
• Tom: nr 12
• Strony: 9--15
• Opis fizyczny: Bibliogr. 15 poz., il. kolor.

Twórcy

autor

Romaniuk, Krzysztof

• Instytut Chemii Organicznej, Wydział Chemiczny, Politechnika Łódzka,

Bibliografia

• [1] Magliano D. J., Boyko E. J., 2021, IDF DIABETES ATLAS, 10 edition, Brussels: International Diabetes Federation.
• [2] Portal Żywienie ma znaczenie, Anonim, 2022, Cukrzyca - powikłania i skutki, https://zywieniemaznaczenie.pl/cukrzyca-powiklania-i-skutki/, 07.11.2023.
• [3] Gusarov D. A., Gusarova V. D., Bayramashvili D. I., Mironov A. F., 2008, Genetically engineered insulin and its pharmaceutical analogues, Biochemistry Supplement Series B: Biomedical Chemistry, Moscow, 2(4), 356-366.
• [4] Quianzon C. C., Cheikh I., 2012, History of insulin, Journal of Community Hospital Internal Medicine Perspectives, 2(2), article 18701.
• [5] Ayan E., DeMirci H., 2023, A Brief Atlas of Insulin, Current Diabetes Reviews, tom 19(6), article no. e100622205849.
• [6] Jarosinski M. A., Dhayalan B., Chen Y.-S., Chatterjee D., Varas N., Weiss M. A., 2021, Structural principles of insulin formulation and analog design: A century of innovation Molecular Metabolism, 52, article 101325.
• [7] National Center for Biotechnology Information, PubChem Compound Summary for Database PubChem, Insulin Glargine, 08.10.2023.
• [8] Jacoby E., Hua Q. X., Stern A. S., Frank B. H., Weiss M. A., 1996, Structure and Dynamics of a Protein Assembly.1H-NMR Studies of the 36 kDa R6 Insulin Hexamer, Journal of Molecular Biology, 258(1), 136-157.
• [9] Moore M. C., Smith M. S., Sinha V. P., Beals J. M., Michael M.D., Jacober S. J., Cherrington A. D., 2014, Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism, Diabetes, 63(2), 494-504.
• [10] Wronkowitz N., Hartmann T., Görgens S. W., Dietze-Schroeder D., Indrakusuma I., Choi I. Y., Park S. H., Lee Y., Kwon S. C., Kang Y., Hompesch M., Eckel J., 2017, LAPS Insulin115 : A novel ultra-long-acting basal insulin with a unique action profile, Diabetes, Obesity and Metabolism, 19(12), 1722-1731.
• [11] Faust C., Ochs C., Korn M., Werner U., Jung J., Dittrich W., Schiebler W., Schauder R., Rao E., Langer T., 2020, Production of a novel heterodimeric two-chain insulin-Fc fusion protein, Protein Engineering, Design and Selection, 14(33), article gzaa026.
• [12] Hansen B. F., Kurtzhals P., Jensen A. B., Dejgaard A., Russell-Jones D., 2011, Insulin X10 revisited: a super-mitogenic insulin analogue, Diabetologia, 54(9), 2226-2231.
• [13] Baghban Taraghdari Z., Imani R., Mohabatpour F., 2019, A Review on Bioengineering Approaches to Insulin Delivery: A Pharmaceutical and Engineering Perspective, Macromolecular Bioscience 19(4), article 1800458.
• [14] Wang J., Yu J., Zhang Y., Kahkoska A. R., Wang Z., Fang J., Whitelegge J. P., Li S., Buse J. B., Gu Z., 2019, Glucose transporter inhibitor-conjugated insulin mitigates hypoglycemia, Proceedings of the National Academy of Sciences, 116(22), 10744-10748.
• [15] Chen Y.-S., Gleaton J., Yang Y., Dhayalan B., Phillips N. B., Liu Y., Broadwater L., Jarosinski M. A., Chatterjee D., Lawrence M. C., Hattier T., Michael M. D., Weiss M. A., 2021, Insertion of a synthetic switch into insulin provides metabolite-dependent regulation of hormone-receptor activation, Proceedings of the National Academy of Sciences, 118(30), article e2103518118.